Efficacy and Long-Term Safety of Ragweed (Ambrosia Artemisiifolia) Sublingual Tablet (SCH 39641) in Adults With a History of Ragweed-Induced Rhinoconjunctivitis With or Without Asthma (Study P05234)

NCT00770315 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

784

Enrollment

INDUSTRY

Sponsor class

Conditions

Rhinitis, Allergic
Conjunctivitis

Interventions

BIOLOGICAL: Ambrosia artemisiifolia allergen extract (Amb a 1-U)
BIOLOGICAL: Placebo

Sponsor

ALK-Abelló A/S